Network Insights Methodology Whitepaper Get Access

FDA

ORG Government / Drug and Device Regulation Momentum 64.3ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

FDA (6,900 employees, $6.5B budget) regulates drugs, devices, and food products representing ~20% of US consumer spending. Accelerated 53 novel drug approvals in 2025 and shifted policy toward expanded over-the-counter access for naloxone, glucose monitors, and generic treatments.

-0.08
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
64.3
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
45
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
FDA is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
White House PlocamiumAI United States HHS AstraZeneca Dr. Novo Nordisk WASHINGTON Robert F. Kennedy Jr. Eli Lilly CMS China RFK Jr. Americans Europe
Watch This Entity
PSI Intelligence
30-Day Trend
2026-06-06 2026-07-06 51 0 Degree Mentions
Signal Decomposition
Attention Cascade
-0.446
Narrative Drift
0.000
Spectral Shift
665.534
Sentiment-Momentum Divergence
0.000
Source Concentration
0.752
Signal
FDA is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #688 of 1196 in Government — in line with sector peers. PSI up 0.43 from yesterday (-0.51 -> -0.08).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
688 of 1196
Sector Rank
-0.09
Peer Z-Score
42%
Sector Percentile
Network Analysis
45 Degree Centrality
Ego Network (top connections)
White House (weight 50.0)PlocamiumAI (weight 45.0)United States (weight 43.0)HHS (weight 36.0)AstraZeneca (weight 32.0)Dr. (weight 28.0)Novo Nordisk (weight 26.0)WASHINGTON (weight 25.0) White HousePlocamiumAIUnited StatesHHSAstraZenecaDr.Novo NordiskWASHINGTON FDA (degree 45) FDA
Centrality History
2026-06-06 2026-07-06 51 0 Degree Mentions
EntityWeight StatusFirst Seen
White House 50 STABLE
PlocamiumAI 45 NEW
United States 43 STABLE
HHS 36 STABLE
AstraZeneca 32 NEW
Dr. 28 STABLE
Novo Nordisk 26 NEW
WASHINGTON 25 STABLE
Robert F. Kennedy Jr. 24 NEW
Eli Lilly 18 NEW
CMS 17 STABLE
China 17 STABLE
RFK Jr. 17 NEW
Americans 16 NEW
Europe 14 STABLE
President 12 STABLE
Reuters 11 STABLE
CEO 10 STABLE
AP 9 STABLE
U.S. Department of Health and Human Services 9 NEW
Canada 8 STABLE
Supreme Court 8 STABLE
Merck 8 STABLE
Senate 7 NEW
California 6 STABLE
Asia 6 STABLE
Donald Trump 6 STABLE
GOP 6 STRENGTHENED
CDC 6 STABLE
WSJ 6 NEW
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-07-06 ← Intelligence Network